Medical devices, healthcare technology and the business of care
510(k) clearance · K261997

NeuroAlign

Medivis, Inc. · Decision date Oct 26, 2026

MEDTECHLEDGER EXPLANATIONK261997

What did the FDA decide?

Medivis, Inc. received a substantially equivalent (SESE) decision for NeuroAlign, a Class II neurological stereotaxic instrument under 21 CFR 882.4560, product code HAW, in the neurology specialty. The FDA decision date is October 26, 2026; the public 510(k) record lists a June 15, 2026 date received, while the summary cover letter states October 1, 2026. The summary identifies NeuroAlign Software (K231897) as the predicate and describes a software-based cranial image-guided navigation system with an optical see-through head-mounted display.

The changed items are an Atracsys spryTrack 300 external optical tracking camera, used in an external camera tracking mode where the workstation provides the navigation display and the HMD is an optional adjunct, plus added reusable surgical accessories. The summary states clinical testing was not required and that nonclinical results supported the determination. SESE is a 510(k) clearance, not a PMA approval. The summary does not quantify performance results, and the reviewed excerpts do not include the full indications-for-use text or the specific reusable accessories.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Neurology
Decision date
Oct 26, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261997
Regulatory pathway
510(k) premarket notification
Applicant
Medivis, Inc.
Product code
HAW
Decision code
SESE
Decision date
Oct 26, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Neurological Stereotaxic Instrument.

Applicant
Medivis, Inc.
Product code
HAW
FDA device class
2

FDA decision timeline

  1. K261997 received

    Application receipt date recorded by FDA.

  2. K261997 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code HAW

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medivis, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
New York, NY

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records